Publicaciones
-
Cerulli Irelli E, Cocchi E, Ramantani G, Morano A, Riva A, Caraballo RH, Giuliano L, Yilmaz T, Panagiotakaki E, Operto FF, Giraldez BG, Balestrini S, Silvennoinen K, Casciato S, Comajuan M, Fortunato F, Giallonardo AT, Gamirova R, Coppola A, Di Gennaro G, Labate A, Sofia V, Kluger GJ, Gambardella A, Kasteleijn-Nolst Trenite D, Baykan B, Sisodiya SM, Arzimanoglou A, Striano P and Di Bonaventura C.
Sex-based electroclinical differences and prognostic factors in epilepsy with eyelid myoclonia
EPILEPSIA . 64(6): 105-111. Nº de citas: 6
-
Sourbron, J, Auvin, S, Arzimanoglou A, Cross, JH, Hartmann, H, Pressler, R, Riney, K, Sugai, K, Wilmshurst, JM, Yozawitz, E and Lagae, L.
Medical treatment in infants and young children with epilepsy: Off-label use of antiseizure medications. Survey Report of ILAE Task Force Medical Therapies in Children
Epilepsia Open . 8(1): 77-89. Nº de citas: 17
-
Henshall DC, Arzimanoglou A, Dedeurwaerdere S, Guerrini R, Jozwiak S, Kokaia M, Lerche H, Pitkänen A, Ryvlin P, Simonato M and Sisodiya SM.
Shaping the future of European epilepsy research: Final meeting report from EPICLUSTER
EPILEPSY RESEARCH . 189: 107068-107068. Nº de citas: 2
-
Brunklaus A, Brünger T, Feng T, Fons-Estupina C, Lehikoinen A, Panagiotakaki E, Vintan MA, Symonds J, Andrew J, Arzimanoglou A, Delima S, Gallois J, Hanrahan D, Lesca G, MacLeod S, Marjanovic D, McTague A, Nuñez-Enamorado N, Perez-Palma E, Scott Perry M, Pysden K, Russ-Hall SJ, Scheffer IE, Sully K, Syrbe S, Vaher U, Velayutham M, Vogt J, Weiss S, Wirrell E, Zuberi SM, Lal D, Møller RS, Mantegazza M and Cestèle S.
The gain of function SCN1A disorder spectrum: novel epilepsy phenotypes and therapeutic implications
BRAIN . 145(11): 3816-3831. Nº de citas: 126
-
Chávez López EK, Aparicio J, Carlos Valera Dávila, Campistol-Plana J, Ramírez-Camacho A, Fons-Estupina C and Arzimanoglou A.
Pre-surgical evaluation challenges and long-term outcome in children operated on for Low Grade Epilepsy Associated brain Tumors
EUROPEAN JOURNAL OF PAEDIATRIC NEUROLOGY . 41: 55-62. Nº de citas: 3
-
Blumcke, I, Biesel, E, Bedenlier, S, Handel, M, Wilmshurst, J, Mehndiratta, MM, Yacubian, EM, Cendes, F, Arzimanoglou A, Beniczky, S, Wolf, P, Giavasi, C, Baxendale, S, Shisler, P and Wiebe, S.
A structured, blended learning program towards proficiency in epileptology: the launch of the ILAE Academy Level 2 Program
EPILEPTIC DISORDERS . 24(5): 737-750. Nº de citas: 11
-
Martinez-Esteve Melnikova A, Pijuan-Marquilles J, Aparicio J, Ramírez-Camacho A, Altisent A, Vilanova-Adell A, Arzimanoglou A, Armstrong-Moron J, Palau F, Hoenicka J and San Antonio-Arce MV.
The p.Glu787Lys variant in the GRIA3 gene causes developmental and epileptic encephalopathy mimicking structural epilepsy in a female patient
European Journal of Medical Genetics . 65(3): 104442-104442. Nº de citas: 7
-
Arzimanoglou A, Pringsheim, M, Kluger, GJ, Genton, P, Perdomo, C and Malhotra, M.
Safety and efficacy of rufinamide in children and adults with Lennox- Gastaut syndrome: A post hoc analysis from Study 022
EPILEPSY & BEHAVIOR . 124: . Nº de citas: 6
-
Balestrini, S, Arzimanoglou A, Blumcke, I, Scheffer, IE, Wiebe, S, Zelano, J and Walker, MC.
The aetiologies of epilepsy
EPILEPTIC DISORDERS . 23(1): 1-16. Nº de citas: 103
-
Uchitel J, Wallace K, Tran L, Abrahamsen T, Hunanyan A, Prange L, Jasien J, Caligiuri L, Pratt M, Rikard B, Fons-Estupina C, De Grandis E, Vezyroglou A, Heinzen EL, Goldstein DB, Vavassori R, Papadopoulou MT, Cocco I, Moré R, Arzimanoglou A, Panagiotakaki E, Mikati MA, Duke AHC Research Group and French AHC Consortium.
Alternating hemiplegia of childhood: evolution over time and mouse model corroboration
Brain Communications . 3(3): . Nº de citas: 15
